Thomas Richard Kassberg Insider Trading $RARE Ultragenyx Pharmaceutical Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Thomas Richard Kassberg.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Thomas Richard Kassberg. Thomas Richard Kassberg is in INTERMUNE INC ($ITMN) and Sr. Vice President in INTERMUNE INC ($ITMN) and SVP, Corp. Dev. & Comm. Oper. in INTERMUNE INC ($ITMN) and SVP-Business Development in INTERMUNE INC ($ITMN) and SVP-Corp. Dev.& Comm. Oper. in INTERMUNE INC ($ITMN) and CBO & EVP in Ultragenyx Pharmaceutical Inc. ($RARE) and CBO & Senior Vice President in Ultragenyx Pharmaceutical Inc. ($RARE).

Thomas Richard Kassberg in Ultragenyx Pharmaceutical Inc.

Trading Symbol: RARE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas Richard Kassberg: CBO & EVP, CBO & Senior Vice President
Holdings: 106,818 shares
Current Value: $7,788,100
Latest Transaction: May 10 2021
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Thomas Richard Kassberg in Ultragenyx Pharmaceutical Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ITMN, RARE

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 10 2021	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Sell	S	113.69	363	41,269	106,818	107.2 K to 106.8 K (-0.34 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Option Exercise	A	142.47	11,000	1,567,170	11,000
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Sell	S	138.17	4,572	631,713	107,181	111.8 K to 107.2 K (-4.09 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	4,636	0	111,614	107 K to 111.6 K (+4.33 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	5,500	0	106,978	101.5 K to 107 K (+5.42 %)
Oct 16 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Sell	S	87.98	262	23,051	101,478	101.7 K to 101.5 K (-0.26 %)
Jun 03 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	69.38	348	24,144	101,740	102.1 K to 101.7 K (-0.34 %)
May 08 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	66.26	248	16,432	101,675	101.9 K to 101.7 K (-0.24 %)
Apr 21 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	58.57	248	14,525	101,923	102.2 K to 101.9 K (-0.24 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Option Exercise	A	56.08	20,000	1,121,600	20,000
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	56.08	2,067	115,917	102,171	104.2 K to 102.2 K (-1.98 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	5,634	0	104,109	98.5 K to 104.1 K (+5.72 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	6,800	0	98,475	91.7 K to 98.5 K (+7.42 %)
Oct 16 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	1,434	0	91,675	90.2 K to 91.7 K (+1.59 %)
Jun 04 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	54.93	346	19,006	90,241	90.6 K to 90.2 K (-0.38 %)
May 22 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	59.50	381	22,670	90,587	91 K to 90.6 K (-0.42 %)
May 07 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	1,434	0	90,968	89.5 K to 91 K (+1.60 %)
Apr 23 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	64.43	248	15,979	89,226	89.5 K to 89.2 K (-0.28 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Option Exercise	A	67.55	21,500	1,452,325	21,500
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	67.55	806	54,445	89,499	90.3 K to 89.5 K (-0.89 %)
Mar 04 2019	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	7,000	0	90,305	83.3 K to 90.3 K (+8.40 %)
Jun 04 2018	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	73.73	346	25,511	83,114	83.5 K to 83.1 K (-0.41 %)
May 22 2018	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	64.79	381	24,685	83,460	83.8 K to 83.5 K (-0.45 %)
Apr 19 2018	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	1,431	0	83,529	82.1 K to 83.5 K (+1.74 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Option Exercise	A	48.43	30,000	1,452,900	30,000
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	48.43	307	14,868	82,098	82.4 K to 82.1 K (-0.37 %)
Mar 05 2018	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	6,000	0	82,405	76.4 K to 82.4 K (+7.85 %)
Jun 01 2017	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	56.61	376	21,285	76,228	76.6 K to 76.2 K (-0.49 %)
May 22 2017	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Payment of Exercise	F	57.47	414	23,793	76,604	77 K to 76.6 K (-0.54 %)
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Option Exercise	A	88.80	25,000	2,220,000	25,000
Mar 01 2017	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & EVP	Grant	A	0.00	3,000	0	76,790	73.8 K to 76.8 K (+4.07 %)
Jun 03 2016	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & Senior Vice P ...	Option Exercise	A	70.57	24,000	1,693,680	24,000
Jun 03 2016	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & Senior Vice P ...	Grant	A	0.00	4,000	0	73,790	69.8 K to 73.8 K (+5.73 %)
May 24 2016	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & Senior Vice P ...	Payment of Exercise	F	64.01	414	26,500	69,790	70.2 K to 69.8 K (-0.59 %)
Aug 14 2015	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & Senior Vice P ...	Sell	S	109.70	3,334	365,740	70,204	73.5 K to 70.2 K (-4.53 %)
Jul 10 2015	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & Senior Vice P ...	Sell	S	102.12	3,334	340,468	73,538	76.9 K to 73.5 K (-4.34 %)
Jun 12 2015	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & Senior Vice P ...	Sell	S	88.19	3,334	294,025	76,872	80.2 K to 76.9 K (-4.16 %)
May 27 2015	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & Senior Vice P ...	Option Exercise	A	84.89	26,300	2,232,607	26,300
May 27 2015	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & Senior Vice P ...	Grant	A	0.00	4,400	0	80,206	75.8 K to 80.2 K (+5.80 %)
May 15 2015	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & Senior Vice P ...	Sell	S	72.04	3,334	240,181	75,806	79.1 K to 75.8 K (-4.21 %)
Apr 10 2015	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & Senior Vice P ...	Sell	S	58.02	3,333	193,381	79,140	82.5 K to 79.1 K (-4.04 %)
Mar 13 2015	RARE	Ultragenyx Pharmac ...	Kassberg Thomas Richard	CBO & Senior Vice P ...	Sell	S	56.30	3,333	187,648	82,473	85.8 K to 82.5 K (-3.88 %)

Page: 1